BioHarvest Sciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	19.17	23.03	2.39	5.36	1.74	4.12
Short-Term Investments	1	-	-	-	-	-
Cash & Short-Term Investments	20.17	23.03	2.39	5.36	1.74	4.12
Cash Growth	493.00%	863.39%	-55.37%	208.47%	-57.83%	130.90%
Accounts Receivable	3.18	2.92	1.81	1.23	1.21	0.62
Inventory	4.97	4.56	3.66	2.47	1.38	0.93
Total Current Assets	28.32	30.5	7.86	9.05	4.32	5.67
Net Property, Plant & Equipment	16.8	16.73	16.77	5.77	4.91	4.36
Other Long-Term Assets	0.44	0.43	0.37	0.18	0.16	0.18
Total Assets	45.56	47.67	25	15	9.39	10.21
Accounts Payable	5.31	4.8	7.13	3.85	2.81	2.15
Accrued Expenses	0.33	0.39	0.4	0.46	0.16	0.14
Short-Term Debt	1.73	0.15	3.91	-	-	-
Current Portion of Long-Term Debt	-	-	-	20.53	8.55	-
Current Portion of Leases	1.27	1.41	0.77	0.38	-	-
Unearned Revenue	0.47	0.49	0.91	0.72	-	-
Other Current Liabilities	0.46	0.45	1.14	0.53	-	0.64
Total Current Liabilities	9.58	7.68	14.26	26.47	11.52	2.92
Long-Term Debt	0.79	2.42	-	-	-	-
Long-Term Leases	10.25	10.13	9.14	1.43	1.67	2.27
Other Long-Term Liabilities	1.92	1.98	0.27	1.96	2.13	2.16
Total Long-Term Liabilities	12.96	14.53	9.41	3.39	3.8	4.43
Total Liabilities	22.54	22.22	23.67	29.86	15.32	7.35
Common Stock	133.22	133	97.75	68.65	65.01	62.56
Retained Earnings	-110.19	-107.55	-96.42	-83.51	-70.94	-59.71
Shareholders' Equity	23.02	25.45	1.33	-14.85	-5.93	2.86
Total Liabilities & Equity	45.56	47.67	25	15	9.39	10.21
Total Debt	14.04	14.1	13.82	22.34	10.22	2.27
Net Cash (Debt)	6.13	8.92	-11.43	-16.99	-8.48	1.84
Net Cash Growth	-31.31%	-	-	-	-	-
Net Cash Per Share	0.31	0.48	-0.71	-1.25	-0.65	0.15
Book Value	23.02	25.45	1.33	-14.85	-5.93	2.86
Book Value Per Share	1.17	1.38	0.08	-1.10	-0.45	0.23
Tangible Book Value	23.02	25.45	1.33	-14.85	-5.93	2.86
Tangible Book Value Per Share	1.17	1.38	0.08	-1.10	-0.45	0.23

SEC Filings: 10-K · 10-Q